This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.
aim 1 : To determine th efficacy of antioxidant therapy in decreasing oxidative stress and acute phase inflammatory biomarkers in stage III and IV chronic kidney disease (CKD) patients.
aim 2 : To determine if antioxidant therapy will improve endothelial vascular function in stage III and IV CKD patients.
Showing the most recent 10 out of 515 publications